The CHA2DS2-VASc risk score predicts successful endovascular treatment in patients with acute ischemic stroke

Erdoğan Yaşar1, Yahya Akalın2, İbrahim Aktaş1

  • 1Department of Cardiology, Malatya Training and Research Hospital, Malatya, Turkey.

Insights

The CHA2DS2-VASC score predicts endovascular intervention success in acute ischemic stroke patients. Higher scores indicate a greater risk of unsuccessful treatment, aiding in risk stratification for stroke patients.

Area of Science:

  • Neurology
  • Cardiology
  • Interventional Radiology

Background:

  • Acute ischemic stroke is a leading cause of death and disability globally.
  • Percutaneous endovascular intervention is a critical treatment for ischemic stroke, with success directly impacting patient outcomes.
  • The CHA2DS2-VASC score is a validated tool for assessing stroke risk in patients with atrial fibrillation.

Purpose of the Study:

  • To investigate the association between the CHA2DS2-VASC score and the success of endovascular intervention in acute ischemic stroke patients.
  • To determine if the CHA2DS2-VASC score can predict intervention failure.

Main Methods:

  • A retrospective analysis of 102 patients with acute ischemic stroke undergoing endovascular intervention.
  • Recording of admission CHA2DS2-VASC scores for all participants.
  • Evaluation of the correlation between TICI scores (indicating intervention success) and CHA2DS2-VASC scores post-procedure.

Main Results:

  • Patients with unsuccessful interventions had significantly higher CHA2DS2-VASC scores (5.02 ± 1.77) compared to those with successful interventions (2.78 ± 1.44).
  • A CHA2DS2-VASC score ≥3 was identified as a predictor of unsuccessful intervention (76.6% sensitivity, 83.3% specificity, AUC 0.827).
  • Atrial fibrillation and higher CHA2DS2-VASC scores were independent predictors of intervention failure in multivariate analysis.

Conclusions:

  • The CHA2DS2-VASC score is significantly associated with the success of endovascular interventions in acute ischemic stroke.
  • This score can serve as a valuable tool for predicting intervention outcomes and guiding clinical decision-making.
  • Risk stratification using the CHA2DS2-VASC score may help optimize treatment strategies for stroke patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
41
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
153
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
46
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63